Deciphering Prostate Cancer: How Genomic Biomarkers are Shaping Treatment Decisions – Paul Nguyen
Neil Desai and Paul Nguyen discuss the integration of the Decipher genomic biomarker in prostate cancer treatment. The conversation centers on two trials, NRG-GU009 and GU010, which utilize Decipher genomic classifiers to tailor treatment intensity, particularly in hormonal therapy. Dr. Nguyen emphasizes the shift from traditional metrics like PSA and Gleason scores to more precise genomic…